Terms: = Breast cancer AND HOXA9, HOX1, 3205, ENSG00000078399, HOX1G, P31269 AND Treatment
4 results:
1. Longitudinal adherence to surveillance for late effects of cancer treatment: a population-based study of adult survivors of childhood cancer.
Shuldiner J; Sutradhar R; Lau C; Shah N; Lam E; Ivers N; Nathan PC
CMAJ; 2024 Mar; 196(9):E282-E294. PubMed ID: 38467416
[TBL] [Abstract] [Full Text] [Related]
2. Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA.
Kjær IM; Kahns S; Timm S; Andersen RF; Madsen JS; Jakobsen EH; Tabor TP; Jakobsen A; Bechmann T
Sci Rep; 2023 May; 13(1):8419. PubMed ID: 37225860
[TBL] [Abstract] [Full Text] [Related]
3. DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment.
Sarno F; Nebbioso A; Altucci L
Epigenetics; 2020 May; 15(5):439-453. PubMed ID: 31790636
[TBL] [Abstract] [Full Text] [Related]
4. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract] [Full Text] [Related]
